Evaluation of the contribution of cytochrome P450 3A4 to human liver microsomal bupropion hydroxylation

Drug Metabolism and Disposition

Volumn 29, Issue 8, 2001, Pages 1123-1129

  Faucette, Stephanie R ^a   Hawke, Roy L ^a   Shord, Stacy S ^a   Lecluyse, Edward L ^a   Lindley, Celeste M ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; COMPLEMENTARY DNA; CYTOCHROME P450 2B6; CYTOCHROME P450 3A4; CYTOCHROME P450 INHIBITOR; DRUG METABOLITE; OXYGENASE; TROLEANDOMYCIN;

ARTICLE; ASSAY; CONCENTRATION RESPONSE; DRUG METABOLISM; DRUG SELECTIVITY; ENZYME ACTIVITY; EVALUATION; HUMAN; HUMAN CELL; HYDROXYLATION; KINETICS; LIVER MICROSOME; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; BUPROPION; CYTOCHROME P-450 ENZYME SYSTEM; DNA; HUMANS; HYDROXYLATION; KINETICS; MICROSOMES, LIVER; MIXED FUNCTION OXYGENASES;

EID: 0034936401     PISSN: 00909556     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Enhanced cyclophosphamide and ifosfamide activation in primary human hepatocyte cultures: Response to cytochrome P-450 inducers and autoinduction by oxazaphosphorines
2. Disposition of bupropion in healthy volunteers and subjects with alcoholic liver disease
3. Development of a comprehensive panel of antibodies against the major xenobiotic metabolizing forms of cytochrome P450 in humans
4. Further characterization of the expression in liver and catalytic activity of CYP2B6
5. Validation of bupropion hydroxylation as a selective marker of human cytochrome P450 2B6 catalytic activity
6. Bupropion in depression: II. The role of metabolites in clinical outcome
7. CYP2B6 mediates the in vitro hydroxylation of bupropion: Potential drug interactions with other antidepressants
8. Catalytic role of cytochrome P4502B6 in the N-demethylation of S-mephenytoin
9. The nuclear orphan receptor CAR-retinoid X receptor heterodimer activates the phenobarbital-responsive enhancer module of the CYP2B gene
10. Pharmacokinetics of bupropion and its metabolites in cigarette smokers versus nonsmokers
11. Carbamazepine but not valproate induces bupropion metabolism
12. Lack of effect of cimetidine on the pharmacokinetics of sustained-release bupropion
13. Pharmacokinetics of bupropion and its major basic metabolites in normal subjects after a single dose
14. Induction of CYPIA, CYP2A, CYP2B, CYP2C, and CYP3A by various drugs and prototypical inducers in primary cultures of human hepatocytes
15. The human orphan nuclear receptor PXR is activated by compounds that regulate CYP3A4 gene expression and cause drug interactions
16. Production and purification of antibodies against rat liver P450 enzymes
17. Bupropion and anticonvulsant drug interactions
18. Antidepressant response and plasma concentrations of bupropion
19. Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: Studies with liver microsomes of 30 Japanese and 30 Caucasians
20. 5
21. Sigmoidal kinetic model for two cooperative substrate-binding sites in a cytochrome P450 3A4 active site: An example of the metabolism of diazepam and its derivatives
22. The repressed nuclear receptor CAR responds to phenobarbital in activating the human CYP2B6 gene
23. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheet: Procedure and some applications
24. Cooperativity in oxidations catalyzed by cytochrome P450 3A4
25. Metabolism of drugs by cytochrome P450
26. Radioselectivity and stereoselectivity of androgen hydroxylations catalyzed by cytochrome P450 isozymes purified from phenobarbital induced rat liver
27. Pharmacological significance of the species differences in bupropion metabolism
28. In vitro metabolism of bupropion by human liver microsomes and cDNA expressed human cytochrome P450's